Cambridge: AstraZeneca has announced that Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory ...
Ayurveda Day and Dhanteras: Prime Minister Narendra Modi launched health-linked projects worth nearly Rs 12,850 crore on ...
The European Commission (EC) has approved AstraZeneca's Fasenra (benralizumab) as an add-on therapy for adults with relapsing ...
Two presidential guards and a Central Intelligence Officer (CIO), Monday appeared in court on allegations of extorting a Chinese miner US$2,000. The three are Chamunorwa Victor Chinorwiwa (32), Hilary ...
AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ...
AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union as an add-on treatment for adults with eosinophilic granulomatosis ...
New indication supported by the MANDARA trial, which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroidsAstraZeneca’s Fasenra (benralizumab) ...
AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients ...
Manohar S Shetty elected as the new prez of Sri Lakshmi Janardhana Temple management committee, Kaup
Manohar S Shetty Kaup, managing director of Udupi Sai Radha Group of Institutions has been unanimously elected as the new ...
(Alliance News) - AstraZeneca PLC on Monday welcomed approval in the European Union of Fasenra for the treatment of eosinophilic granulomatosis with polyangiitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback